We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$121B
AUM Growth
+$6.29B
Cap. Flow
+$257M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.67%
Holding
4,045
New
183
Increased
1,650
Reduced
1,805
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 15.49%
2 Financials 8.61%
3 Healthcare 8.48%
4 Industrials 6.86%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTNR
3576
DELISTED
Vertex Energy, Inc
VTNR
$125K ﹤0.01%
+20,003
New +$141K
MFIN icon
3577
Medallion Financial
MFIN
$253M
$124K ﹤0.01%
15,725
BTAI icon
3578
BioXcel Therapeutics
BTAI
$28.8M
$124K ﹤0.01%
1,166
+288
+33% +$95.9K
ZIM icon
3579
ZIM Integrated Shipping Services
ZIM
$2.96B
$124K ﹤0.01%
10,009
+512
+5% +$8.23K
UEIC icon
3580
Universal Electronics
UEIC
$74.6M
$124K ﹤0.01%
12,838
+847
+7% +$7.84K
EXAI
3581
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$123K ﹤0.01%
20,828
CIO
3582
DELISTED
City Office REIT
CIO
$122K ﹤0.01%
21,858
-948
-4% -$5.17K
FSP
3583
Franklin Street Properties
FSP
$45.8M
$122K ﹤0.01%
83,892
-186
-0.2% -$257
VZ icon
3584
PUT
Verizon
VZ
$196B
$122K ﹤0.01%
2,700
PATI
3585
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$121K ﹤0.01%
14,326
GERN icon
3586
Geron
GERN
$1.05B
$121K ﹤0.01%
37,700
SBI
3587
Western Asset Intermediate Muni Fund
SBI
$107M
$121K ﹤0.01%
15,816
-258
-2% -$1.99K
TLRY icon
3588
Tilray
TLRY
$651M
$120K ﹤0.01%
7,712
-3,862
-33% -$82.8K
SRPT icon
3589
CALL
Sarepta Therapeutics
SRPT
$1.92B
$120K ﹤0.01%
+1,000
New +$129K
AUPH icon
3590
Aurinia Pharmaceuticals
AUPH
$2.04B
$119K ﹤0.01%
12,300
+500
+4% +$5.19K
WEA
3591
Western Asset Premier Bond Fund
WEA
$125M
$119K ﹤0.01%
11,672
-3,000
-20% -$31K
SJT
3592
San Juan Basin Royalty Trust
SJT
$126M
$119K ﹤0.01%
16,000
+1,375
+9% +$11.7K
FCT
3593
First Trust Senior Floating Rate Income Fund II
FCT
$119K ﹤0.01%
11,991
-2,223
-16% -$21.5K
DWSH icon
3594
AdvisorShares Dorsey Wright Short ETF
DWSH
$6.18M
$118K ﹤0.01%
13,498
-165,741
-92% -$1.53M
WNEB icon
3595
Western New England Bancorp
WNEB
$281M
$118K ﹤0.01%
20,199
+1,600
+9% +$10.4K
CGEN icon
3596
Compugen
CGEN
$227M
$117K ﹤0.01%
102,625
-1,000
-1% -$872
MIN
3597
Aberdeen Intermediate Income Fund
MIN
$280M
$115K ﹤0.01%
42,032
-10,113
-19% -$28.2K
EPD icon
3598
PUT
Enterprise Products Partners
EPD
$81.8B
$115K ﹤0.01%
5,000
YUMC icon
3599
PUT
Yum China
YUMC
$16.3B
$115K ﹤0.01%
+2,000
New +$121K
CANO
3600
DELISTED
Cano Health, Inc.
CANO
$115K ﹤0.01%
825
-99
-11% -$12.7K

Similar funds

Raymond James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Raymond James & Associates held 4,045 positions worth $121B, up 5.5% from $115B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q2 2023 filing shows 183 new, 1,650 increased, 1,805 reduced and 213 closed positions. Its largest new stake was Choice Hotels: 212,259 shares worth $24.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $562M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2023 buy was Choice Hotels: 212,259 shares worth $24.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2023, an estimated $753M increase.
  • Raymond James & Associates's biggest Q2 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $562M.
  • Raymond James & Associates fully exited ABB Ltd in Q2 2023, selling an estimated $17.1M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $121B portfolio in Q2 2023.
  • Raymond James & Associates opened 183 new positions and closed 213 in Q2 2023.
  • Raymond James & Associates's portfolio value rose 5.5% quarter-over-quarter to $121B.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.